↩ Go Back
Need help?

Biotechnology Businesses for Sale and Investment Opportunities in Asia

Showing 1 - 15 of 18 Biotechnology Businesses for Sale and Investment Opportunities in Asia. Buy or Invest in a Biotechnology, Agricultural Biotechnology, Biotech Facility, Biopharma, Bio Diagnostic, Bio Medical Device or a Bio Therapeutic Drug Business.

Filters
  • Biotechnology

  • Asia

 

Bio Diagnostic Franchise Opportunity

Enbiosis Biotechnology, Established in 2021, 13 Franchisees, London Headquartered
  • 10+ introductions
  • 700+ Page Views
  • 200+ Investor Views
- Company and product: Enbiosis has developed an advanced artificial intelligence algorithm that analyzes the human gut microbiome and recommends personalized food and supplements to individuals to improve their gut health and address chronic disorders such as gastrointestinal disorders, skin-related disorders, and weight loss issues. - How it works: Patients/customers send their stool samples to any NGS laboratory in their region. Enbiosis takes the raw bacterial DNA data to the local server (to avoid data protection risks) and creates a personalized report, which is sent to patients and, if required, their practitioners within minutes. - Business model: Enbiosis's microbiome test can be sold through practitioners and/or directly to customers, depending on market dynamics. Practitioners can prescribe the test to patients to generate a personalized diet plan, or patients can follow their personalized nutrition guide through the app to improve general well-being and solve their problems. - Main differentiation: Enbiosis is the only clinically proven precision diet technology that claims to address the main cause of chronic disorders. It has conducted three clinical trials and published the results in peer-reviewed journals. Enbiosis's claims are backed by scientific evidence. - The main reason why investors should consider Enbiosis: In recent years, the number of people seeking to address their health problems through alternative methods instead of pharmaceuticals has been increasing. The challenge in alternative medicine is the lack of scientific data. Enbiosis serves as a bridge between alternative medicine and conventional medicine, and there is significant market potential for Enbiosis. For example, Enbiosis has proven the effectiveness of its technology in patients with IBS, who make up about 10% of the population. Offering individuals the opportunity to solve their chronic problems simply by changing their diet within a specific period is something they are interested in and willing to try. - Additionally, investors/distributors can offer a routine follow-up program to check gut health and prevent any kind of diseases, opening the door to long-term recurring revenue. - We have a trade registration certificate to operate.
Enbiosis Biotechnology, Established in 2021, 13 Franchisees, London Headquartered
9.5   Expanding in China
Exp Monthly Sales
USD 190 thousand
Space Required
0 - 80 Sq Ft
Investment Required
USD 60 K
Contact Company

Bio Therapeutic Drugs Company Investment Opportunity in Navi Mumbai, India

Seeking Investment: US FDA approved R&D company with 5+ pharma clients in Europe.
- We do the R&D for big pharma companies. - Innovative formulation development with a focus on quality-by-design principles for precise and effective therapeutic solutions. - Commitment to excellence reflected in crafting products that redefine healthcare standards. - Fusion of innovation and precision, guided by scientific rigor, transforming pharmaceutical science into life-changing solutions. - Expertise in product development, CDMO, CMO, and TT services for five major clients, including big pharma companies. - Promoters bring 15 years of experience in R&D and product development. - Client base includes European companies, demonstrating international reach. - Regulatory approvals from the FDA and ISO 17025 underscore the company's commitment to quality and compliance. - Adaptive workforce with contract workers based on demand. - High growth attributed to the acquisition of new clients, showcasing the company's expanding market presence.
6.5   Navi Mumbai
Run Rate Sales
USD 700 thousand
EBITDA Margin
40 %
Financial Investment
USD 1.2 Mn for 10%
Contact Business

Biotechnology Business Investment Opportunity in Bangalore, India

Seeks Investment: Business manufactures structured nano silicon and has 200+ dealers for the product.
- The business produces 2nm - 8nm of structured nano silicon which helps increase the yield drastically. - Ours is a unique product that works for organic and Inorganic farming. - It is very economical and reduces farmers' input burden. - Our product also reduces the farmer's expenses and gives them a minimum of 20-40% extra yield. - We have a marketing capability to supply the whole of India. - We have received good reviews from farmers and our dealers. - The manufacturing capacity is 10k ltrs/ month. - We have about 200 dealers who supply our products to the farmers. - The cost of 1L of our product is INR 1.7k, and our production cost is INR 460. - The owner has an experience of 6-7 years in the business.
6.2   Bangalore
Run Rate Sales
USD 60 thousand
EBITDA Margin
25 %
Financial Investment
USD 120 K for 10%
Contact Business

Biotechnology Company Investment Opportunity in Thiruvananthapuram, India

Genomic-based healthcare solutions company with global scale-up potential seeks investment.
- Offer genetic testing and wellness management services, currently reaching 1,069 customers. - Product development completed, revenue generation started, franchisee appointments, academic programs, and community projects in progress. - Company that provides clients with a vision & understanding of their unique genetic profile and its implication for better wellness. - The field of health genomics has matured in the past two decades and is beginning to deliver genomic-based interventions for health and health care. Every human being will have huge amounts of genetic variation that create the unique individuality seen in a person. - Generate revenue by charging fees for tests to conduct. We charge around INR 20,000-60,000 for consumer genomic tests. - We have 32 employees (lab team, technical team, genetic team, customer support team, and marketing team). - The promoter has 13 years of experience in this industry.
Genomic-based healthcare solutions company with global scale-up potential seeks investment.
8.8   Thiruvananthapuram
Run Rate Sales
USD 70 thousand
EBITDA Margin
20 - 30 %
Financial Investment
USD 600 K for 20%
Contact Business

Biotechnology Business Seeking Loan in Monaragala, Sri Lanka

Business involved in the manufacture and sale of tissue-cultured mushroom seeds receiving 150 orders daily.
- Business is involved in the sale of tissue-cultured mushroom seeds. - The owner has an experience of 7+ years in this industry. - One pack of tissue-cultured mushroom seeds weighs 200g and is sold for LKR 150. - The demand is very high, we receive around 150 orders every day and our machine has a manufacturing capacity of 100 packs per day. - The packs are directly sold to customers. - The promotor has received the best entrepreneur award in Monaragala, Sri Lanka. - Most of the work of the business is done through the machines and this is the reason for us to have limited employees. And we need these employees to operate the business from manufacturing to packaging.
5.4   Monaragala
Run Rate Sales
USD 4 thousand
EBITDA Margin
30 - 40 %
Business Loan
USD 6.5 K at 12%
Contact Business

Biotechnology Company Investment Opportunity in Pune, India

Company conducting clinical trials for nutraceuticals, herbal and cosmetic products seeks investment.
- Have catered to 60+ clients. We have clients from 6 different countries. - We have tied up with a network of 150 hospitals across 30 cities to conduct the trials. - The clinical trials are conducted in multiple sites. - We have 13 ongoing collaborations with pharmaceutical companies or research institutions. - Average duration of the clinical trials is 5 months. - We abide by the ICH-GCP guidelines to handle the confidentiality and privacy of participants' data during and after the trial. - One project takes 4-5 months and we receive the entire amount post-completion of the project itself.
7.2   Pune
Run Rate Sales
USD 360 thousand
EBITDA Margin
20 %
Financial Investment
USD 240 K for 2%
Contact Business

Biotechnology Company for Sale in Mohali, India

For Sale: Company providing quality biotech training to students.
- 300 students have registered for the current year. - No. can be increased provided full fledge market franchisees are given. - In the field of biotechnology training we are next to the top-notch leaders. - Promoter has 12-13 years of experience in this industry.
7.5   Mohali
Run Rate Sales
USD 65 thousand
EBITDA Margin
30 - 40 %
Business for Sale
USD 170 K
Contact Business

Bio Therapeutic Drugs Company Investment Opportunity in Bangalore, India

BioIntelligent consumer healthcare company- OTC supplements, home & hygiene, intimate care, hair & skin category.
We have launched 15 innovative products. The products are planned for sales through omni channel marketing. We have presence in general trade and ecommerce. We need to enter into exports, modern trade and multiple market places. .
8.4   Bangalore
Run Rate Sales
USD 600 thousand
EBITDA Margin
25 %
Financial Investment
USD 360 K for 35%
Contact Business

Bio Therapeutic Drugs Company Investment Opportunity in Pune, India

Biopharma company having rights of 15 formulations looking to establish a manufacturing unit in USA.
- We are a biopharma company dealing in the research and development of various formulations and clinical trials. - As of now the company has rights of 15 formulations and has a large market share in this industry. - Our company has two revenue models. We treat patients majorly from the countries such as Australia, Canada, and the USA using our technology. - These patients especially travel to India for our treatments. - We don't have our own clinics but subcontract hospitals in Mumbai to use our technology. - Another revenue source is to supply our formulations and technology to various other hospitals & clinics and receive a royalty from them. - We also have discussions going on with various insurance companies to provide coverage for our treatments. - Since the majority of our clients are from the USA we are planning to start a drug manufacturing unit there. - This unit will be under the USFDA regulations which would increase our scope to expand into various other international markets. - The company has two partners with a 70% and 30% stake distribution. - Business has not taken any loans previously. - We are seeking investment to establish the manufacturing unit.
7.7   Pune
Run Rate Sales
USD 100 thousand
EBITDA Margin
30 %
Financial Investment
USD 800 K for 30%
Contact Business

Bio Medical Devices Company Investment Opportunity in New Delhi, India

New Delhi-based biomedical device manufacturer and distributor with a patent product, seeking funds for marketing.
- Our business is a startup company that the first Indian paper-based nano-sensor device, which will detect bacterial infection and antibiotic resistance in 90 minutes. - Company has done 2 and a half years of product research and development before deploying it to Phase 1 testing of product trial and safe use. - Our products are used by our new clients some of which have provided us grants for the phase 2 product developments. - Some of our reputed clients are LG electronic and IIT Delhi, and several hospitals. - We have sold out our products in the last 4 months. - Business has received 4 grants from IIT Delhi, FDI, and many more worth INR 1 crore. - We have medical pieces of equipment which are imported from Germany and Sweden for our medical research and product research. - Our products were first sold for INR 1,200 per 100 ml bottle, but due to the covid situation, we decide to cut the cut to INR 899 per 100 ml bottles. - The promoter has 8 years of experience in the biomedical devices business. - Our business has not taken any kind of business loan and does not have any outstanding balance so far.
New Delhi-based biomedical device manufacturer and distributor with a patent product, seeking funds for marketing.
6.3   New Delhi
Run Rate Sales
USD 110 thousand
EBITDA Margin
20 %
Financial Investment
USD 240 K for 10%
Contact Business

Bio Diagnostics Company Investment Opportunity in Bangalore, India

Investor sought by a bootstrapped R&D lab developing tools for precision medicine in cancer.
- Bio-diagnostic research company developing a cancer diagnosis, prognosis, and discovery tool. - Promoter has set up a laboratory with his own funds. - The laboratory has the basic equipment necessary to develop the product. - The lab has a collaboration with a French laboratory. - Developing proof of concept as of now. - We require funds to hire technical manpower and conduct trials in hospitals. - The promoter has a doctorate in Neurobiology from France with 15 years of industrial experience in similar areas. They have experience in oncology as well. - Looking for investors to bring the ideas into reality. The investor will receive a 30% stake in the company.
6.3   Bangalore
Run Rate Sales
Nil
EBITDA Margin
Nil
Financial Investment
USD 600 K for 30%
Contact Business

Bio Diagnostics Business Investment Opportunity in Pune, India

Variety of diagnostic kits for healthcare, infertility, drones, agriculture, food, ngs, research and biotechnology.
- Our company is essentially a biotechnology organization that sells proprietary diagnostic kits for healthcare and biotechnology research kits along with services. - These kits allow our customers to evaluate various parameters by themselves. - We have more than 40 in-house researched products. Manufacturing is done at our own premises. - Our products are sold to 32 distributors who further sell them at pharmacies and hospitals across India. Kits are also sold in Saudi Arabia, Dubai, Ukraine, Sudan and Zimbabwe. We do not sell our products directly to any customers. - Revenue plummeted this year due to the effect of the pandemic on the market. - The business is extremely valuable due to our vast array of products, IP, and enormous growth potential in the future.
Variety of diagnostic kits for healthcare, infertility, drones, agriculture, food, ngs, research and biotechnology.
7.0   Pune
Run Rate Sales
USD 1.2 million
EBITDA Margin
10 - 20 %
Financial Investment
USD 600 K for 15%
Contact Business

Biotechnology Company Investment Opportunity in Chennai, India

Nano biotech company specializing in developing medicine for animals and human seeks investment for product validation.
- Business is registered in Thanjavur with headquarters in Chennai. Business has 3 incubation centres in different IITs of India, a branch in California and a development lab near Chennai. - 2-3 employees are located in California and the rest of the staff Chennai and Mumbai. - We develop different types of medicines, disinfectants, wound spray for animals and humans. - We have developed 10 products so far using 4 types of development technologies. - After the medicines are validated, will either transfer the technology to pharma companies or manufacture the products by partnering with pharmaceutical companies. - Will generate revenue by royalties and product sales. - In talks with international brands for technology transfer. Once the product validation is completed, we can start generating revenue.
5.9   Chennai
Run Rate Sales
Nil
EBITDA Margin
Nil
Financial Investment
USD 2 Mn for 20%
Contact Business

Biotechnology Company Investment Opportunity in Mysore, India

Plant biotechnology, Jatropha Biodiesel and Medicinal plants.
- We sell planting kits for various plants and fruits. - These planting kits are sold to farmers, wholesale nurseries and government agencies across India. - We are now looking to begin selling medicinal plant kits. - The kit will include useful scientific tips for growing and using at the household level through retail online and offline marketing. - We would provide strong biotechnological and scientific support. - Our aim is to fill the gap in the demand existing in the retail market for medicinal plants. - Revenue has decreased due to covid-19.
7.6   Mysore
Run Rate Sales
USD 140 thousand
EBITDA Margin
20 - 30 %
Financial Investment
USD 360 K for 10%
Contact Business

Biotechnology Business Investment Opportunity in Chennai, India

Stem Cell company providing customized services for therapeutic requirements.
- Company does business on Advanced Stem Cell technologies such as hypoxic stem cell tech, immunomodulation tech, and advanced cancer stem cell technology, - Our services include clinical stem cell protocol services, stem cell procedures, stem cell education, consultancy and comprehensive establishment of stem cell centres including advanced stem cell laboratories - for hospital, industrial, and clinical services. - Founder is a stem cell scientist with over 20 years of experience in the industry. - We provide advanced stem cell technology transfers, therapy consultancy, stem cell therapy technology, stem cell academic services, advanced stem cell laboratory erections, platforms and applications. - Have trained more than 100 doctors, Scientists and professors in Stem Cell field across the world. - Established and Delegated Technologies for 6 Units (including for foreign establishments)
7.9   Chennai
Run Rate Sales
USD 220 thousand
EBITDA Margin
40 %
Financial Investment
USD 36 Mn for 40%
Contact Business

Frequently
Asked
Questions

  • How many biotechnology businesses for sale and investment opportunities in Asia are listed on SMERGERS?
    There are 18 active and verified biotechnology businesses for sale and investment opportunities in Asia listed on SMERGERS as of 28 March 2024.
  • What level of due diligence does SMERGERS conduct on the businesses/member?

    SMERGERS scrutinizes all profiles and only features a select group of businesses, investors, advisors that meet a basic requirement. When required, certain members may have submitted some form of proof …read more

  • How active are the business profiles listed on SMERGERS?

    We regularly filter out businesses which are inactive or have already closed a transaction. Typically, if the business is actively looking to sell/raise capital, the status is shown in green.

  • How can I be sure about privacy and confidentiality?

    We understand the level of confidentiality required in strategic transactions and we strive to provide a safe and secure experience for our members. Please review our privacy policy. We …read more

  • How can I contact a business listed on SMERGERS?

    You need to be logged in before you connect with a business. Click here to register and message the business If you are already logged in, please use the contact …read more

  • Should you buy an existing business or start a business from scratch?

    Buying an existing business is generally an easier way to start a business with an immediate head start. It saves valuable time and administrative efforts, considering starting from scratch is …read more

  • How successful has SMERGERS been in helping its users successfully close a deal?

    SMERGERS is a discovery and matchmaking platform with a global reach. It helps in connecting Businesses, Investors, Acquirers, Lenders, M&A Advisors and Boutique Investment Banks across locations, industries and transactions. …read more

  • Show more